AN-019 T26625
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
AN-019, a Bcr-Abl kinase inhibitor, is used potentially for the treatment of chronic myeloid leukemia.
CAS nr:
879507-25-2
Purity:
98%
Molecular Weight:
517,44
SMILES:
O=C(NC1=CC=C(C)C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1)C4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4
Formula:
C25H17F6N5O
Pathway:
Target:
